(Q33999149)

30 July 2017

1 reference

title

Management of graft-versus-host disease in paediatric bone marrow transplant recipients (English)

1 reference

30 July 2017

Zecca M

1

1 reference

30 July 2017

Locatelli F

series ordinal

2

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

2

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

29-55

1 reference

https://scigraph.springernature.com/pub.10.2165/00148581-200002010-00004

30 July 2017

exact match

0 references

cites work

Complications in the use of the SPM chi 2 statistic.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00148581-200002010-00004

Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00148581-200002010-00004

PUVA therapy for chronic cutaneous graft-vs-host disease

21 January 2018

1 reference

12 December 2020

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

12 December 2020

Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts

1 reference

12 December 2020

Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study

1 reference

12 December 2020

In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease

1 reference

12 December 2020

One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation

1 reference

12 December 2020

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

12 December 2020

Lymphocyte dysfunction in chronic graft-versus-host disease

1 reference

12 December 2020

Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment

1 reference

12 December 2020

Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction

1 reference

12 December 2020

Human marrow T cell dose correlates with severity of subsequent acute graft-versus-host disease

1 reference

12 December 2020

Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone

1 reference

12 December 2020

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome

1 reference

12 December 2020

Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study

1 reference

12 December 2020

A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT

1 reference

12 December 2020

Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial

1 reference

12 December 2020

Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma.

1 reference

12 December 2020

Oral manifestations of chronic graft-v-host disease

1 reference

12 December 2020

Predictive Factors in Chronic Graft-Versus-Host Disease in Patients with Aplastic Anemia Treated by Marrow Transplantation from HLA-Identical Siblings

1 reference

12 December 2020

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

12 December 2020

Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.

1 reference

12 December 2020

Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood

1 reference

12 December 2020

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

12 December 2020

Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings

1 reference

12 December 2020

Transfusions and grafts of homologous bone marrow in humans after accidental high dosage irradiation

1 reference

12 December 2020

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.

1 reference

12 December 2020

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

12 December 2020

Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease

1 reference

12 December 2020

Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.

1 reference

12 December 2020

Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy

1 reference

12 December 2020

PUVA therapy for drug-resistant graft-versus-host disease

1 reference

12 December 2020

Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia

1 reference

12 December 2020

Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors

1 reference

12 December 2020

Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10)

1 reference

12 December 2020

Chronic graft-vs.-host disease of the liver: another indication of ursodeoxycholic acid?

1 reference

12 December 2020

Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias

1 reference

12 December 2020

FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors

1 reference

12 December 2020

Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia

1 reference

12 December 2020

Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination

1 reference

12 December 2020

Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial

1 reference

12 December 2020

Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation

1 reference

12 December 2020

A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy

1 reference

12 December 2020

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection

1 reference

12 December 2020

Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease

1 reference

12 December 2020

Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease

1 reference

12 December 2020

Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients

1 reference

12 December 2020

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease

1 reference

12 December 2020

Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants

1 reference

12 December 2020

FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group

1 reference

12 December 2020

Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease

1 reference

12 December 2020

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment

1 reference

12 December 2020

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

1 reference

12 December 2020

The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information

1 reference

12 December 2020

Chronic graft-versus-host disease

1 reference

12 December 2020

Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1.

1 reference

12 December 2020

Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors

1 reference

12 December 2020

Topical cyclosporin A for treatment of oral chronic graft-versus-host disease

1 reference

12 December 2020

Treatment of chronic graft-versus-host disease with clofazimine

1 reference

12 December 2020

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

12 December 2020

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

1 reference

12 December 2020

Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study

1 reference

12 December 2020

Specific suppressor cells in graft-host tolerance of HLA-identical marrow transplantation

1 reference

12 December 2020

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

12 December 2020

Total lymphoid irradiation for treatment of drug resistant chronic GVHD

1 reference

12 December 2020

ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival

1 reference

12 December 2020

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

1 reference

12 December 2020

Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

1 reference

12 December 2020

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection

1 reference

12 December 2020

Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor

1 reference

12 December 2020

Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3.

1 reference

12 December 2020

A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation

1 reference

12 December 2020

Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease.

1 reference

12 December 2020

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

12 December 2020

What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?

1 reference

12 December 2020

Molecular pathogenesis of cholestasis.

1 reference

12 December 2020

Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation

1 reference

12 December 2020

Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity.

1 reference

12 December 2020

An increased risk of relapse in cyclosporin-treated compared with methotrexate-treated patients: long-term follow-up of a randomized trial

1 reference

12 December 2020

8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.

1 reference

12 December 2020

Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody

1 reference

12 December 2020

FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation

1 reference

12 December 2020

Thalidomide as salvage therapy for chronic graft-versus-host disease

1 reference

12 December 2020

A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease

1 reference

12 December 2020

Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival

1 reference

12 December 2020

Thalidomide and the immune system. 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells.

1 reference

12 December 2020

Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia

1 reference

12 December 2020

Analysis of late infections in 89 long-term survivors of bone marrow transplantation

1 reference

12 December 2020

Cytokine dysregulation and acute graft-versus-host disease

1 reference

12 December 2020

Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells

1 reference

12 December 2020

Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival

1 reference

12 December 2020

Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation

1 reference

12 December 2020

Recognition, incidence, and management of oral graft-versus-host disease

1 reference

12 December 2020

Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine

1 reference

12 December 2020

Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

1 reference

12 December 2020

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

12 December 2020

Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation

1 reference

12 December 2020

Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy

1 reference

12 December 2020

Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?

1 reference

12 December 2020

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

1 reference

12 December 2020

Identification and induction of keratinocyte-derived IL-10

1 reference

12 December 2020

Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse

1 reference

12 December 2020

Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP)

1 reference

12 December 2020

1994 Consensus Conference on Acute GVHD Grading

1 reference

12 December 2020

Successful treatment of steroid-resistant severe acute GVHD with 24-h continuous infusion of FK506

1 reference

12 December 2020

Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement

1 reference

12 December 2020

Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia

1 reference

12 December 2020

A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease.

1 reference

12 December 2020

The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children

1 reference

12 December 2020

Thalidomide and the immune system 2. Changes in receptors on blood cells of a healthy volunteer

1 reference

12 December 2020

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

12 December 2020

Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease

1 reference

12 December 2020

Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention

1 reference

12 December 2020

Antihuman thymocyte globulin for prophylaxis of graft-versus-host disease. A randomized trial in patients with leukemia treated with HLA-identical sibling marrow grafts

1 reference

12 December 2020

Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial

1 reference

12 December 2020

T-cell depletion of HLA-identical transplants in leukemia.

1 reference

12 December 2020

Thalidomide treatment for chronic graft-versus-host disease

1 reference

12 December 2020

Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.

1 reference

12 December 2020

Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients

1 reference

12 December 2020

Acute graft-versus-host disease: pathogenesis and prevention with a monoclonal antibody in vivo

1 reference

12 December 2020

Recent advances in graft-versus-host disease (GVHD) prevention

1 reference

12 December 2020

Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate

1 reference

12 December 2020

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia

1 reference

12 December 2020

Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials

1 reference

12 December 2020

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

12 December 2020

Prophylaxis and treatment of acute graft-versus-host disease: current state, implications of new immunopharmacologic compounds and future strategies to prevent and treat acute GVHD in high-risk patients.

1 reference

12 December 2020

Ursodeoxycholic acid for primary sclerosing cholangitis

1 reference

12 December 2020

Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506

1 reference

12 December 2020

Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.

1 reference

12 December 2020

Failure of early administration of antithymocyte globulin to lessen graft-versus-host disease in human allogeneic marrow transplant recipients

1 reference

12 December 2020

Production of Graft-Versus-Host Disease in the Rat and its Treatment with Cytotoxic Agents

1 reference

12 December 2020

Prophylaxis of graft-versus-host disease in identical sibling donor bone marrow transplant by anti-IL-2 receptor monoclonal antibody LO-Tact-1.

1 reference

12 December 2020

Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression

1 reference

12 December 2020

Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation

1 reference

12 December 2020

A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment

1 reference

12 December 2020

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.

1 reference

12 December 2020

Graft-versus-host disease

1 reference

12 December 2020

Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts

1 reference

12 December 2020

Oral pilocarpine hydrochloride for the treatment of refractory xerostomia associated with chronic graft-versus-host disease

1 reference

12 December 2020

Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation

1 reference

12 December 2020

Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA)

1 reference

12 December 2020

Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients

1 reference

12 December 2020

Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG).

1 reference

12 December 2020

Effect of Thalidomide on the Graft versus Host Reaction

1 reference

12 December 2020

The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome

1 reference

12 December 2020

Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease

1 reference

12 December 2020

Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures

1 reference

12 December 2020

Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation.

1 reference

12 December 2020

The pharmacology and clinical use of methotrexate

1 reference

12 December 2020

Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis

1 reference

12 December 2020

1 reference

12 December 2020

PUVA and cancer: a large-scale epidemiological study

1 reference

12 December 2020

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

12 December 2020

Treatment of acute graft-versus-host disease with monoclonal antibody OKT3. Clinical results and effect on circulating T lymphocytes

1 reference

12 December 2020

Cyclosporine-A as GVHD prophylaxis in allogeneic BMT for childhood acute leukemia. AIEOP-BMT group

1 reference

12 December 2020

Removal of marrow T cells with OKT3-OKT11 monoclonal antibodies and complement to prevent acute graft-versus-host disease. A pilot study in ten patients

1 reference

12 December 2020

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma

1 reference

12 December 2020

Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.

1 reference

12 December 2020

Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease

1 reference

12 December 2020

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

12 December 2020

Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia

1 reference

12 December 2020

Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro

1 reference

12 December 2020

Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors

1 reference

12 December 2020

Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation

1 reference

12 December 2020

FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors

1 reference

12 December 2020

Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A.

1 reference

12 December 2020

Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease

1 reference

12 December 2020

Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies

1 reference

12 December 2020

8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease

1 reference

12 December 2020

Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease

1 reference

12 December 2020

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

12 December 2020

Ocular Manifestations of Graft-vs-Host Disease

1 reference

12 December 2020

Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts

1 reference

12 December 2020

Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies

1 reference

12 December 2020

Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease

1 reference

12 December 2020

Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia

1 reference

12 December 2020

Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease

1 reference

12 December 2020

Topical retinoid treatment for various dry-eye disorders

1 reference

12 December 2020

Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial

1 reference

12 December 2020

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

12 December 2020

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.

1 reference

12 December 2020

Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A

1 reference

12 December 2020

Cell membrane DNA: a new target for psoralen photoadduct formation

1 reference

12 December 2020

Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood.

1 reference

12 December 2020

In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation

1 reference

12 December 2020

Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid

1 reference

12 December 2020

Cytokine release by peripheral blood mononuclear cells is affected by 8-methoxypsoralen plus UV-A

1 reference

12 December 2020

Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool

1 reference

12 December 2020

Treatment of established human graft-versus-host disease by antithymocyte globulin.

1 reference

12 December 2020

Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids

1 reference

12 December 2020

Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

12 December 2020

Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease

1 reference

12 December 2020

10.2165/00148581-200002010-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1035434672

0 references

1 reference